Unlock instant, AI-driven research and patent intelligence for your innovation.

Chroman derivative and preparation method and application thereof

A derivative, the technology of chroman, applied in the field of pharmacy, achieves the effects of novel structure, excellent ACC inhibitory activity and broad development prospects

Active Publication Date: 2019-03-01
CHINA PHARM UNIV
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, the research on ACC inhibitors at home and abroad is in the clinical and preclinical research stage, and no drug has been approved for marketing. It is necessary to study compounds with more diverse structural types to obtain ideal drugs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chroman derivative and preparation method and application thereof
  • Chroman derivative and preparation method and application thereof
  • Chroman derivative and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0085] 8',8'-Dimethyl-1-(7-methyl-1H-indole-5-carbonyl)-7',8'-dihydro-6'H-spiro[piperidine-4,2' -pyrone[3,2-g]benzopyran]-4'(3'H)-one (I-1),

[0086]

[0087] Step 1) 1-(7-Hydroxy-2,2-dimethylchroman-6-yl) ethyl ketone

[0088] Put 8g (52.80mmol) of 2,4-dihydroxyacetophenone and 150mL of 1,4-dioxane into a 250mL three-necked flask, and stir at room temperature until completely dissolved. Add 11.20 mL (0.11 mol) boron trifluoride ether solution drop by drop, and stir at room temperature until the solution turns pink. Then, 7.19 g (0.11 mol) of isoprene in 1,4-dioxane (25 mL) was added dropwise, and the solution turned purple-black, and stirred overnight at room temperature. After the reaction was detected by TLC, saturated ammonium chloride solution (50mL) was added to the reaction solution, extracted with ethyl acetate (60mL×3), the organic phases were combined, and the organic phase was washed with saturated sodium chloride solution (50mL). It was dried over sodium sulf...

Embodiment 2

[0097] 8',8'-Dimethyl-1-(2-phenyl-1H-benzimidazole-5-carbonyl)-7',8'-dihydro-6'H-spiro[piperidine-4,2 '-Pyrone[3,2-g]benzopyran]-4'(3'H)-one (I-2)

[0098]

[0099] The synthesis procedure was the same as in Example 1, and 69 mg of white solid was obtained, with a melting point of 219-221° C. and a yield of 77%.

[0100] 1 H NMR (300MHz, DMSO-d 6 )δ13.05(s,1H),8.35–8.21(m,1H),7.87–7.69(m,3H),7.60(d,J=9.1Hz,3H),7.50(s,1H),7.25(d ,J=8.3Hz,1H),6.34(s,1H),4.21(s,2H),3.69(s,2H),2.81–2.64(m,4H),1.92(s,2H),1.84–1.71( m,4H),1.29(s,6H).MS(ESI)m / z: calculated for C 32 h 31 N 3 o 4 [M-H] - :520.2, found: 520.2.

Embodiment 3

[0102] 8',8'-Dimethyl-1-(7-methyl-2-propyl-1H-benzimidazole-5-carbonyl)-7',8'-dihydro-6'H-spiro[piper Pyridine-4,2'-pyrone[3,2-g]benzopyran]-4'(3'H)-one (I-3)

[0103]

[0104] The synthesis steps were the same as in Example 1, and 70 mg of white solid was obtained, with a melting point of 175-177° C. and a yield of 70%.

[0105] 1 H NMR (300MHz, DMSO-d 6 )δ12.19(s,1H),7.49(s,1H),7.34(s,1H),6.98(s,1H),6.33(s,1H),4.17(s,2H),2.80(t,J =7.5Hz,2H),2.72(d,J=8.9Hz,4H),2.49(s,3H),2.01–1.63(m,8H),1.29(s,6H),0.94(t,J=7.4Hz ,3H).MS(ESI)m / z: calculated for C 30 h 35 N 3 o 4 [M+Na] + :524.3,found:524.3.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a chroman derivative. The structure of the chroman derivative is shown in a formula (I) (Please see the specifications for the formula (I)). According to the chroman derivative, the structure is novel, excellent ACC inhibitory activity and non-alcoholic fatty liver disease resisting activity in vivo are achieved, and transcription of fatty acid from de novo synthesis genes,inflammation related genes and liver fibrosis related genes can be significantly lowered; and intestinal microecology disturbance induced by high-fat food can be further improved. The chroman derivative and medicinal salt thereof can be used for treating or preventing non-alcoholic fatty liver disease, alcoholic fatty liver disease and metabolic syndromes, excellent drug safety is shown, and broad development prospects are achieved.

Description

technical field [0001] The invention belongs to the technical field of pharmacy, and in particular relates to a chroman derivative and its preparation method and application. Background technique [0002] The incidence of nonalcoholic fatty liver disease (NAFLD) is increasing year by year all over the world, and it has become the second most serious liver disease after viral hepatitis in China; its main feature is excessive accumulation of fat in liver cells, Including simple fatty liver (Simple fatty liver, SFL), nonalcoholic steatohepatitis (Nonalcoholic steatosis heptitis, NASH), liver fibrosis, liver cirrhosis and hepatocellular carcinoma. Nonalcoholic fatty liver disease is often accompanied by obesity, insulin resistance, hyperlipidemia and other related metabolic syndromes, and has a common part with the pathogenesis of alcoholic liver disease. At present, there is no specific treatment for nonalcoholic fatty liver disease. drug. [0003] Acetyl-CoA carboxylase (Ace...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D491/20A61K31/438A61K31/4709A61K31/444A61K31/5377A61K31/506A61P1/16A61P3/00
CPCA61P1/16A61P3/00C07D491/20Y02P20/55
Inventor 张惠斌王丽蕊魏强强钱民怡高颖生周金培梅连阔胡海洋
Owner CHINA PHARM UNIV